(28 days)
The Navitrack® System -- OS Unicondylar Knee Universal is indicated for use as a stereotaxic instrument to assist in the positioning of unicondylar knee replacement components intra-operatively.
It is a computer controlled image-guidance system equipped with a three-dimensional tracking sub-system. It is intended to assist the surgeon in determining reference alignment axes in relation to anatomical landmarks, and in precisely positioning the alignment instruments relative to these axes by displaying their locations.
The Navitrack System - OS Unicondylar Knee Universal device consists of software, a computer workstation, an optical tracking system, surgical instruments, and tracking accessories, designed to assist the surgeon in the placement of unicondylar knee replacement components.
Tracking devices are incorporated with given surgical instruments, as well as on to fixation bases that attach to each of the femur and tibia, such to allow the ability to track and display to the user their respective positions intra-operatively. The femur and tibia are displayed to the user in the form of their main alignment axes. The alignment axes are determined and recorded intra-operatively by identifying the key anatomical references that are used clinically to align and position the components.
The Navitrack® System – OS Unicondylar Knee Universal is a stereotaxic instrument designed to assist in the positioning of unicondylar knee replacement components intra-operatively. It uses a computer-controlled image-guidance system with a 3D tracking sub-system to determine reference alignment axes and precisely position alignment instruments.
Here's an analysis of the provided information regarding acceptance criteria and the supporting study:
1. Table of Acceptance Criteria and Reported Device Performance
The provided document does not explicitly state numerical acceptance criteria. Instead, it makes a general claim regarding performance compared to a predicate device.
| Acceptance Criterium (Implied) | Reported Device Performance |
|---|---|
| Accuracy and performance adequacy for intended use | "accuracy and performance of the system was adequate for its intended use" |
| Performance not reduced compared to predicate (OS Knee Universal) | "not reduced in comparison to the OS Knee Universal predicate." |
| No new safety and efficacy issues | "no new safety and efficacy issues were raised in the device." |
2. Sample Size Used for the Test Set and Data Provenance
The document states "Non-clinical tests were performed" to assess accuracy and performance. However, it does not specify the sample size used for the test set or the data provenance (e.g., country of origin, retrospective or prospective).
3. Number of Experts Used to Establish the Ground Truth for the Test Set and Qualifications of Those Experts
The document does not provide information on the number of experts used to establish ground truth for the test set or their qualifications.
4. Adjudication Method for the Test Set
The document does not describe any adjudication method used for the test set.
5. If a Multi Reader Multi Case (MRMC) Comparative Effectiveness Study Was Done, and the Effect Size
The document does not mention a multi-reader multi-case (MRMC) comparative effectiveness study or any effect size related to human readers improving with or without AI assistance. The device is described as "assisting the surgeon," implying human involvement, but no formal comparative study with human readers is detailed.
6. If a Standalone (i.e., algorithm only without human-in-the-loop performance) Was Done
The document describes the device as providing "image guidance assistance" to the surgeon, indicating a human-in-the-loop system. It does not state whether a standalone (algorithm-only) performance evaluation was conducted.
7. The Type of Ground Truth Used
The document describes the performance assessment as "non-clinical tests" to verify accuracy and performance. Given the nature of a surgical navigation system, the "ground truth" for accuracy would likely involve:
- Physical measurements/phantoms: Using precise physical models or phantoms where the true anatomical landmarks and alignment axes are known and can be independently verified.
- Engineering specifications/tolerances: Comparing the device's measurements and guidance to pre-defined engineering tolerances for surgical accuracy.
However, the document does not explicitly state the specific type of ground truth used.
8. The Sample Size for the Training Set
The document does not provide any information regarding a training set or its sample size. Since this is a navigation system that digitizes anatomical landmarks and guides instrument placement, it's possible that a "training set" in the traditional machine learning sense might not be applicable or explicitly mentioned as it would be for an AI-diagnostic device. The system's core functionality relies on established anatomical referencing and geometric calculations, rather than a learning algorithm trained on a dataset of cases.
9. How the Ground Truth for the Training Set Was Established
As no training set is mentioned (see point 8), the document does not describe how ground truth for a training set was established.
{0}------------------------------------------------
K071714
510(K) SUMMARY OF SAFETY AND EFFECTIVENESS Navitrack® System – OS Unicondylar Knee Universal
Applicant: ORTHOsoft Inc. 75 Queen Street, suite 3300 Montreal, Quebec Canada, H3C 2N6 Tel.: 514 861 4074 Fax: 514 866 2197
Contact Person: Christopher McLean
Date Summary Prepared: June 21, 2007
Device Trade Name: Navitrack® System – OS Unicondylar Knee Universal
Device Classification Name: Stereotaxic Instrument (84 HAW); 21 CFR § 882.4560
Predicate Devices:
- Navitrack® System - OS Knee Universal; from Orthosoft Inc; 510(k) # K060336 2) Uni Knee Surgetics Navigation System; from Praxim; 510(k) # K062146
Device Description:
The Navitrack System - OS Unicondylar Knee Universal device consists of software, a computer workstation, an optical tracking system, surgical instruments, and tracking accessories, designed to assist the surgeon in the placement of unicondylar knee replacement components.
Tracking devices are incorporated with given surgical instruments, as well as on to fixation bases that attach to each of the femur and tibia, such to allow the ability to track and display to the user their respective positions intra-operatively. The femur and tibia are displayed to the user in the form of their main alignment axes. The alignment axes are determined and recorded intra-operatively by identifying the key anatomical references that are used clinically to align and position the components.
Indications for Use / Intended Use:
The Navitrack® System -- OS Unicondylar Knee Universal is indicated for use as a stereotaxic instrument to assist in the positioning of unicondylar knee replacement components intra-operatively.
It is a computer controlled image-guidance system equipped with a three-dimensional tracking sub-system. It is intended to assist the surgeon in determining reference alignment axes in relation to anatomical landmarks, and in precisely positioning the alignment instruments relative to these axes by displaying their locations.
{1}------------------------------------------------
Technological Comparisons to the Predicate:
The fundamental scientific technology of the predicates is unchanged. The main operating principle and control mechanism are maintained in the proposed device to similarly provide image guidance assistance in the placement of knee orthopedic implants.
While maintaining the same main software features and many of the same instrument components, the OS Knee Universal predicate was modified with secondary instrumentation and software changes to accommodate more specifically the requirements of unicondylar knee replacement techniques as compared to those of bicondylar (total) knee components in the OS Knee Universal predicate.
The main changes to the OS Knee Universal are as follows.
- A new function was added to provide an estimate from the navigation data for the . hip-knee-ankle alignment simultaneously while aligning the saw guides.
- . Alternate alignment axes were included to help to axially orient and position the posterior femoral cut in comparison to the axial rotation,
- Minor changes and improvement were incorporated in the instrument used to . navigate the saw guides from the implant systems, and the instrument used to digitize the cut surfaces was reduced to cover a single condyle instead of the predicate two-condyle design.
Performance Data:
Non-clinical tests were performed to assess that no new safety and efficacy issues were raised in the device. These included tests and analyses to verify that the accuracy and performance of the system was adequate for its intended use and not reduced in comparison to the OS Knee Universal predicate.
Conclusion:
The information and data provided in this 510(k) Premarket Notification established that the Navitrack System - OS Unicondylar Knee Universal Knee device is substantially equivalent to the predicates.
$\frac{2}{2}$
{2}------------------------------------------------
Image /page/2/Picture/1 description: The image shows the logo for the U.S. Department of Health and Human Services. The logo features a stylized caduceus symbol, which is often associated with medicine and healthcare. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" is arranged in a circular pattern around the caduceus. The logo is simple and recognizable, representing the department's role in promoting public health and well-being.
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
JUL 2 0 2007
ORTHOsoft, Inc. % Mr. Christopher McLean RA/QM Director 75 Queen Street, Suite 3300 Montréal, Quebec Canada H3C 2N6
Re: K071714
Trade/Device Name: Navitrack System - OS Unicondylar Knee Universal Regulation Number: 21 CFR 882.4560 Regulation Name: Stereotaxic instrument Regulatory Class: II Product Code: HAW Dated: June 21, 2007 Received: June 22, 2007
Dear Mr. McLean:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug. and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set
{3}------------------------------------------------
Page 2 – Mr. Christopher McLean
forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your deyice to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at (240) 276-0115. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (240) 276-3150 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html .
Sincerely yours,
Mark McMillan
Mark N. Melkerson Director Division of General, Restorative and Neurological Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
{4}------------------------------------------------
510(k) Number:
Device Name: Navitrack® System - OS Unicondylar Knee Universal
Indications for Use.
The Navitrack® System -- OS Unicondylar Knee Universal is indicated for use as a stereotaxic instrument to assist in the positioning of unicondylar knee replacement components intra-operatively.
It is a computer controlled image-guidance system equipped with a threedimensional tracking sub-system. It is intended to assist the surgeon in determining reference alignment axes in relation to anatomical landmarks, and in precisely positioning the alignment instruments relative to these axes by displaying their locations.
Prescription Use V (per 21CFR 801.109) OR
Over-the-Counter Use
Concurrence of CDRH, Office of Device Evaluation (ODE)
__, and I am not going to write it all out.
(Division Sign-Off) Division of General, Restorative. and Neurological Devices
510(k) Number K071714
§ 882.4560 Stereotaxic instrument.
(a)
Identification. A stereotaxic instrument is a device consisting of a rigid frame with a calibrated guide mechanism for precisely positioning probes or other devices within a patient's brain, spinal cord, or other part of the nervous system.(b)
Classification. Class II (performance standards).